Publications by authors named "Franco Aversa"

Claim this Profile
O
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.
Matteo Marchesini, Andrea Gherli, Elisa Simoncini, Lucas Moron Dalla Tor, Anna Montanaro, Franco Aversa

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.
Anna Montanaro, Samuel Kitara, Elisa Cerretani, Matteo Marchesini, Chiara Rompietti, Franco Aversa

Cell Death Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants.
Claudio Costantini, Emilia Nunzi, Angelica Spolzino, Francesco Merli, Luca Facchini, Franco Aversa

Infect Immun· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.
Giorgia Renga, Emilia Nunzi, Marilena Pariano, Matteo Puccetti, Marina Maria Bellet, Franco Aversa

J Immunother Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients.
Claudio Costantini, Emilia Nunzi, Angelica Spolzino, Melissa Palmieri, Giorgia Renga, Franco Aversa

Infect Immun· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolution of T Cell Depleted Haploidentical Transplantation.
Franco Aversa, Antonio Pierini, Loredana Ruggeri, Massimo Fabrizio Martelli, Andrea Velardi

Front Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.
Valerio Napolioni, Marilena Pariano, Monica Borghi, Vasilis Oikonomou, Claudia Galosi, Franco Aversa

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
Matteo Marchesini, Andrea Gherli, Anna Montanaro, Laura Patrizi, Claudia Sorrentino, Franco Aversa

Cell Chem Biol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation.
Stefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, Ephraim J Fuchs, Leo Luznik, Franco Aversa

Bone Marrow Transplant· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT.
Bhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, Leo Luznik, Annalisa Ruggeri, Franco Aversa

Haematologica· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies.
Corrado Girmenia, Tiziana Lazzarotto, Francesca Bonifazi, Francesca Patriarca, Giuseppe Irrera, Franco Aversa

Clin Transplant· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells.
Lucia Prezioso, Ilenia Manfra, Sabrina Bonomini, Chiara Schifano, Roberta Segreto, Franco Aversa

Bone Marrow Transplant· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.
Stefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, Piyanuch Kongtim, Monzr Al Malki, Franco Aversa

Bone Marrow Transplant· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fungaemia in haematological malignancies: SEIFEM-2015 survey.
Marianna Criscuolo, Francesco Marchesi, Anna Candoni, Chiara Cattaneo, Annamaria Nosari, Franco Aversa

Eur J Clin Invest· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Patient's Empowerment rights-duty Charter": new communication tools targeted at patient and professionals in a Hematology and Bone marrow transplant center.
Cipriana Mengozzi, Giovanna Campaniello, Franco Aversa, Francesca Re, Barbara Calatafimi

Acta Biomed· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
Massimo Breccia, Daniela Bartoletti, Massimiliano Bonifacio, Giuseppe A Palumbo, Nicola Polverelli, Franco Aversa

Ann Hematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
Maria Ilaria Del Principe, Giulia Dragonetti, Luisa Verga, Anna Candoni, Francesco Marchesi, Franco Aversa

J Antimicrob Chemother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management.
Corrado Girmenia, Alessandro Busca, Anna Candoni, Simone Cesaro, Mario Luppi, Franco Aversa

Med Mycol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhodotorula infection in haematological patient: Risk factors and outcome.
Leonardo Potenza, Maria N Chitasombat, Nikolay Klimko, Francesca Bettelli, Giulia Dragonetti, Franco Aversa

Mycoses· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukaemia mimicking multiple myeloma.
Laura Notarfranchi, Filomena Russo, Francesca Re, Cristina Mancini, Eugenia Martella, Franco Aversa

Lancet Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC.
Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, Diana Canetti, Denise Madeddu, Franco Aversa

Lung Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients.
Francesca Palandri, Giuseppe A Palumbo, Massimiliano Bonifacio, Massimo Breccia, Roberto Latagliata, Franco Aversa

Leuk Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
Francesca Palandri, Lucia Catani, Massimiliano Bonifacio, Giulia Benevolo, Florian Heidel, Franco Aversa

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study.
Francesca Palandri, Giuseppe A Palumbo, Alessandra Iurlo, Nicola Polverelli, Giulia Benevolo, Franco Aversa

Semin Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Fabrizio Accardi, Valentina Marchica, Cristina Mancini, Elena Maredi, Costantina Racano, Franco Aversa

Hematol Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis